Genben Lifesciences
San Diego, US · Delaware corporation
Founders & leadership
XD
Xiao-Chang DaiNamed on SEC filing
LS
Li ShenNamed on SEC filing
KF
Kenneth FongNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$5.2M disclosed across 1 round · 2018
▶$5.2MraisedMay 2018 · 5 investors · Other Health CareRule 506(b)
▶$5.2MraisedMay 2018 · 5 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Xiao-Chang DaiDirector
- Li ShenExecutive Officer, Director
- Kenneth FongDirector
- Offering amount
- $5.2M
- Amount sold
- $5.2M
- First sale
- May 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2016 | $338.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- How much funding has Genben Lifesciences raised?
- Genben Lifesciences has disclosed $5.2M raised across 1 round.
- Where is Genben Lifesciences headquartered?
- Genben Lifesciences is headquartered in San Diego, US.